<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Full Blood Count Interpretation for Primary Care</title>
    <link rel="stylesheet" href="medical-textbook-styles.css">
</head>
<body>
    <div class="textbook-page">
        <button class="download-btn" onclick="downloadPDF()">
            <svg class="download-icon" fill="currentColor" viewBox="0 0 20 20">
                <path fill-rule="evenodd" d="M3 17a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zm3.293-7.707a1 1 0 011.414 0L9 10.586V3a1 1 0 112 0v7.586l1.293-1.293a1 1 0 111.414 1.414l-3 3a1 1 0 01-1.414 0l-3-3a1 1 0 010-1.414z" clip-rule="evenodd"></path>
            </svg>
            Download PDF
        </button>

        <div class="page-header">
            <h1>Full Blood Count Interpretation</h1>
            <div class="subtitle">A Structured Approach to FBC Analysis in Primary Care</div>
        </div>

        <div class="content">
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">ü©∏</div>
                    <h2>Introduction: Beyond the Numbers</h2>
                </div>
                <p>The Full Blood Count (FBC) remains one of the most powerful diagnostic tools in primary care, yet its interpretation extends far beyond recognising abnormal values. This chapter explores the clinical reasoning that transforms FBC results into actionable patient management decisions, integrating current NICE guidance with practical clinical pearls for safe, effective practice.</p>
                
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"The Pattern Recognition Approach":</strong> Always interpret the FBC as a constellation of findings rather than isolated abnormalities. The combination of MCV, RDW, and reticulocyte count tells the story of what's happening in the bone marrow, while the clinical context determines urgency and next steps.</p>
                </div>

                <p>Modern FBC interpretation must integrate seamlessly with cancer pathway decisions, particularly the revolutionary role of Faecal Immunochemical Testing (FIT) in colorectal cancer referrals. Understanding when an abnormal FBC warrants urgent versus routine investigation can be the difference between appropriate reassurance and missed malignancy.</p>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üö®</div>
                    <h2>Priority Assessment: Red Flags Requiring Immediate Action</h2>
                </div>

                <div class="red-flag-grid">
                    <div class="red-flag-item">
                        <strong>Very Urgent FBC (48 hours)</strong><br>
                        Suspected leukaemia in adults with petechiae, hepatosplenomegaly, or lymphadenopathy
                    </div>
                    <div class="red-flag-item">
                        <strong>Blast Cells on Film</strong><br>
                        Any blast cells visible on blood film require same-day haematology discussion
                    </div>
                    <div class="red-flag-item">
                        <strong>Severe Anaemia</strong><br>
                        Hb <70 g/L with symptoms warrants urgent assessment for transfusion needs
                    </div>
                    <div class="red-flag-item">
                        <strong>Pancytopenia</strong><br>
                        All three cell lines reduced suggests bone marrow pathology requiring urgent referral
                    </div>
                    <div class="red-flag-item">
                        <strong>Thrombocytopenia <50</strong><br>
                        Bleeding risk requires urgent evaluation and specialist input within 48 hours
                    </div>
                    <div class="red-flag-item">
                        <strong>WCC >50 or <1.0</strong><br>
                        Extreme values need immediate haematology consultation before patient leaves practice
                    </div>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"The 3-Parameter Emergency Rule":</strong> Any combination of three or more significantly abnormal FBC parameters (anaemia, leucopenia, thrombocytopenia) should trigger immediate haematology advice and guidance rather than routine referral. This pattern strongly suggests systemic haematological disease requiring urgent evaluation.</p>
                </div>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üìã</div>
                    <h2>Structured History Framework: The Story Behind the Numbers</h2>
                </div>

                <div class="two-column">
                    <div>
                        <h4>Essential Historical Elements</h4>
                        <ul>
                            <li><strong>Timeline and Symptoms:</strong> Acute versus chronic onset helps distinguish between nutritional deficiency and haematological malignancy</li>
                            <li><strong>Bleeding History:</strong> Heavy menstrual periods, GI bleeding, or blood donation can explain iron deficiency patterns</li>
                            <li><strong>Dietary Assessment:</strong> Vegetarian diet, malabsorption history, alcohol excess affecting B12/folate status</li>
                            <li><strong>Medication Review:</strong> Anticoagulants, NSAIDs, methotrexate, and other marrow-suppressive drugs</li>
                        </ul>
                    </div>
                    <div>
                        <h4>Cancer Risk Stratification</h4>
                        <ul>
                            <li><strong>Age and Gender:</strong> Men >50 and post-menopausal women with iron deficiency require GI investigation</li>
                            <li><strong>Constitutional Symptoms:</strong> Weight loss, night sweats, fatigue disproportionate to anaemia degree</li>
                            <li><strong>Family History:</strong> Lynch syndrome, hereditary cancer syndromes affecting referral thresholds</li>
                            <li><strong>Previous Investigations:</strong> Recent normal colonoscopy may alter management approach</li>
                        </ul>
                    </div>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"The Mixed Anaemia Clue":</strong> A normal MCV with elevated RDW suggests mixed deficiency (iron + B12/folate), commonly seen in coeliac disease or inflammatory bowel disease. Always check both haematinics when RDW is raised despite normal MCV.</p>
                </div>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">‚öñÔ∏è</div>
                    <h2>Risk Factor Analysis: Weighting Clinical Significance</h2>
                </div>

                <div class="risk-factors-visual">
                    <div class="risk-factor">Age >50 with Iron Deficiency<br><small>High risk for GI malignancy</small></div>
                    <div class="risk-factor">Thrombocytosis >600<br><small>Consider underlying malignancy</small></div>
                    <div class="risk-factor">Microcytosis + Normal Ferritin<br><small>Think thalassaemia trait</small></div>
                    <div class="risk-factor">Macrocytosis + Normal B12/Folate<br><small>Alcohol, thyroid, liver disease</small></div>
                    <div class="risk-factor">Lymphocytosis >5.0<br><small>Consider CLL in elderly</small></div>
                    <div class="risk-factor">Pancytopenia Pattern<br><small>Urgent haematology referral</small></div>
                </div>

                <div class="highlight-box">
                    <h4>Integration with FIT Testing</h4>
                    <p>For patients with iron deficiency anaemia and colorectal symptoms, FIT testing can inform referral urgency. A FIT ‚â•10 Œºg Hb/g supports urgent 2-week-wait referral, while FIT <10 Œºg Hb/g may allow routine referral with appropriate safety netting. However, men over 50 and post-menopausal women with unexplained iron deficiency still require investigation regardless of FIT result.</p>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"The Ferritin Paradox":</strong> Ferritin as an acute phase reactant can mask iron deficiency in inflammatory conditions. If clinical suspicion remains high with borderline ferritin (30-50 Œºg/L), check transferrin saturation <24% to confirm iron deficiency.</p>
                </div>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üéØ</div>
                    <h2>Clinical Decision Points: When and How to Refer</h2>
                </div>

                <div class="assessment-flow">
                    <div class="flow-step">
                        <h4>Step 1: Immediate Risk Assessment</h4>
                        <p>Check for red flags requiring same-day action. Any patient with suspected acute leukaemia needs very urgent FBC within 48 hours. Severe anaemia with symptoms may need urgent secondary care assessment.</p>
                    </div>
                    <div class="flow-step">
                        <h4>Step 2: Pattern Recognition</h4>
                        <p>Classify anaemia by MCV and RDW. Microcytic anaemia warrants iron studies and consideration of GI investigation. Macrocytic anaemia needs B12/folate assessment. Mixed patterns suggest complex pathology.</p>
                    </div>
                    <div class="flow-step">
                        <h4>Step 3: Cancer Pathway Decision</h4>
                        <p>2-week-wait haematology referral for unexplained lymphadenopathy, splenomegaly, or blood film abnormalities suggesting lymphoproliferative disorder. Consider FIT testing for GI symptoms with anaemia.</p>
                    </div>
                    <div class="flow-step">
                        <h4>Step 4: Safety Netting and Follow-up</h4>
                        <p>Arrange appropriate monitoring intervals. Iron deficiency requires 2-4 week FBC post-treatment initiation. Unexplained abnormalities need clear follow-up plans and patient education about when to re-attend.</p>
                    </div>
                </div>

                <div class="interpretation-grid">
                    <div class="interpretation-item">
                        <h4>Iron Deficiency Anaemia Management</h4>
                        <p>Start ferrous sulphate 200mg TDS, check FBC in 2-4 weeks for response. Continue for 3 months post-correction to replenish stores. Investigate underlying cause unless clear explanation (menstruation, donation).</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>B12/Folate Deficiency</h4>
                        <p>If neurological symptoms present, start IM B12 1mg three times weekly for 2 weeks, then 3-monthly. Check response with FBC and monitor for clinical improvement.</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>Haematology Referral Criteria</h4>
                        <p>Urgent referral for pancytopenia, blast cells, unexplained lymphadenopathy, or blood film suggesting lymphoproliferative disorder. Routine referral for investigation of unexplained cytopenias.</p>
                    </div>
                </div>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üíä</div>
                    <h2>Treatment Response Patterns: Reading the Follow-up Story</h2>
                </div>

                <div class="parameter-grid">
                    <div class="parameter-card normal">
                        <h4>Appropriate Iron Response</h4>
                        <p>Reticulocyte rise within 5-10 days, Hb increase of 10-20 g/L per week indicates good response to oral iron. Continue treatment for 3 months post-normalisation.</p>
                    </div>
                    <div class="parameter-card abnormal-high">
                        <h4>Poor Iron Response</h4>
                        <p>Consider non-compliance, malabsorption, ongoing bleeding, or incorrect diagnosis. May need IV iron or specialist referral if oral treatment fails after adequate trial.</p>
                    </div>
                    <div class="parameter-card abnormal-low">
                        <h4>B12 Treatment Response</h4>
                        <p>Reticulocyte rise within 2-5 days, neurological symptoms may take months to improve. Monitor FBC and adjust injection frequency based on response.</p>
                    </div>
                    <div class="parameter-card critical">
                        <h4>Non-Responsive Anaemia</h4>
                        <p>Failure to respond to appropriate treatment warrants urgent haematology referral. May indicate underlying malignancy, chronic disease, or complex haematological disorder requiring specialist assessment.</p>
                    </div>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"The Treatment Trial as Diagnosis":</strong> In equivocal cases, response to iron supplementation can confirm iron deficiency. Hemoglobin increase after two weeks provides empirical confirmation of diagnosis and treatment response. Non-response should prompt investigation review.</p>
                </div>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üß¨</div>
                    <h2>FIT Testing Integration: Transforming Colorectal Assessment</h2>
                </div>

                <div class="visual-element">
                    <h3>FIT Threshold Interpretation in Primary Care</h3>
                    <div class="reference-range-table">
                        <table>
                            <thead>
                                <tr>
                                    <th>FIT Result</th>
                                    <th>Cancer Risk</th>
                                    <th>Action Required</th>
                                    <th>Clinical Context</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><10 Œºg Hb/g</td>
                                    <td><0.3%</td>
                                    <td>Consider routine referral with safety netting</td>
                                    <td>May manage in primary care if no ongoing concern</td>
                                </tr>
                                <tr>
                                    <td>10-19.9 Œºg Hb/g</td>
                                    <td>1.4%</td>
                                    <td>2-week-wait referral indicated</td>
                                    <td>Above threshold for urgent investigation</td>
                                </tr>
                                <tr>
                                    <td>20-99.9 Œºg Hb/g</td>
                                    <td>3.3%</td>
                                    <td>Urgent 2WW referral</td>
                                    <td>Significant risk requiring prompt investigation</td>
                                </tr>
                                <tr>
                                    <td>‚â•100 Œºg Hb/g</td>
                                    <td>20.7%</td>
                                    <td>Expedited investigation</td>
                                    <td>Very high risk - fast track through system</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"FIT and Blood Results Synergy":</strong> FIT ‚â•4 Œºg Hb/g in the presence of iron deficiency anaemia, low ferritin, or thrombocytosis significantly increases colorectal cancer risk and warrants urgent 2WW referral. The combination provides better risk stratification than either test alone.</p>
                </div>

                <div class="highlight-box">
                    <h4>Important FIT Considerations</h4>
                    <p>FIT should be offered to all patients with lower GI symptoms except those with anal/rectal masses or ulceration. A previous normal screening FIT (120 Œºg Hb/g threshold) does not exclude cancer in symptomatic patients. Always use the 10 Œºg Hb/g threshold for symptomatic assessment.</p>
                </div>
            </div>

            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üìä</div>
                    <h2>Summary: Integrated FBC Interpretation Framework</h2>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"The Complete Assessment Triangle":</strong> Modern FBC interpretation requires integration of (1) haematological parameters and patterns, (2) cancer risk stratification including FIT testing where appropriate, and (3) treatment response monitoring. No single element tells the complete story.</p>
                </div>

                <div class="visual-element">
                    <div class="diagram">
                        <div class="diagram-item">
                            <h4>Pattern Recognition</h4>
                            <p>MCV, RDW, reticulocyte count provide the pathophysiological framework</p>
                        </div>
                        <div class="diagram-item">
                            <h4>Risk Stratification</h4>
                            <p>Age, gender, symptoms, and FIT results determine referral urgency</p>
                        </div>
                        <div class="diagram-item">
                            <h4>Treatment Monitoring</h4>
                            <p>Response patterns confirm diagnosis and guide ongoing management</p>
                        </div>
                    </div>
                </div>

                <div class="critical-values">
                    <h3>Critical Practice Points</h3>
                    <ul>
                        <li>Always check haematinics (ferritin, B12, folate) when anaemia is identified - deficiencies are common and easily treatable</li>
                        <li>Very urgent FBC (48 hours) required for suspected leukaemia with petechiae, hepatosplenomegaly, or lymphadenopathy</li>
                        <li>FIT ‚â•10 Œºg Hb/g with colorectal symptoms warrants 2-week-wait referral regardless of other factors</li>
                        <li>Men >50 and post-menopausal women with unexplained iron deficiency need GI investigation irrespective of FIT result</li>
                        <li>Three or more abnormal FBC parameters suggest systemic disease requiring urgent haematology advice and guidance</li>
                    </ul>
                </div>
            </div>

            <div class="references-section">
                <h3>üîó Clinical Guidelines & Evidence Base</h3>
                <div class="guideline-grid">
                    <div class="guideline-item">
                        <strong>NICE Guideline NG12</strong><br>
                        <em>Suspected cancer: recognition and referral</em> - 2024<br>
                        <a href="https://www.nice.org.uk/guidance/ng12">Access Guidelines</a>
                    </div>
                    <div class="guideline-item">
                        <strong>NICE Diagnostics Guidance 30</strong><br>
                        <em>Quantitative faecal immunochemical tests for colorectal cancer</em> - 2023<br>
                        <a href="https://www.nice.org.uk/guidance/dg30">Access Guidelines</a>
                    </div>
                    <div class="guideline-item">
                        <strong>BSG/ACPGBI Joint Guideline</strong><br>
                        <em>FIT in symptomatic patients with suspected CRC</em> - 2022<br>
                        <a href="https://gut.bmj.com/content/71/10/1939">Access Publication</a>
                    </div>
                    <div class="guideline-item">
                        <strong>NICE Clinical Knowledge Summaries</strong><br>
                        <em>Anaemia - Iron Deficiency</em> - Updated 2024<br>
                        <a href="https://cks.nice.org.uk/topics/anaemia-iron-deficiency/">Access CKS</a>
                    </div>
                    <div class="guideline-item">
                        <strong>British Society for Haematology</strong><br>
                        <em>Guidelines for B12 and folate deficiency</em> - 2022<br>
                        <a href="https://onlinelibrary.wiley.com/doi/10.1111/bjh.17888">Access Guidelines</a>
                    </div>
                    <div class="guideline-item">
                        <strong>NHS England</strong><br>
                        <em>Implementation guidance for FIT in primary care</em> - 2022<br>
                        <a href="https://www.england.nhs.uk/publication/implementing-faecal-immunochemical-testing-fit-in-primary-care/">Access Guidance</a>
                    </div>
                </div>
            </div>

            <div class="page-number">
                Chapter completed - Page 3 of 3<br>
                Full Blood Count Interpretation for Primary Care
            </div>
        </div>
    </div>

    <script src="medical-textbook-scripts.js"></script>
</body>
</html>
